Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
Researchers compared AEVI-001 and placebo to find out how the approaches affected ADHD symptoms in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
In WayneResearchers compared AEVI-001 and placebo to find out how the approaches affected ADHD symptoms in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
In WayneA Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part II
This study has finished and is no longer accepting participants.
Multiple locations, including San FranciscoOpen-Label Trial of Personalized Medication Experiments to Inform Decisions About Future Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Use
This study has finished and is no longer accepting participants.
In Cincinnati
PET Scanning of Brain Dopaminergic Signal Transduction Involving Arachidonic Acid in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In BethesdaA Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including MiamiA Pharmacokinetic Study of Aptensio XR® (Methylphenidate Hydrochloride (HCl) Extended-release) Capsules in Male or Female Pre-School Children 4 to Under 6 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD) in Fed Condition
This study has finished and is no longer accepting participants.
Multiple locations, including South MiamiA Phase 3, Double-blind, Randomized, Placebo-controlled, Multi-center, Fixed-dose, Parallel Group Efficacy and Safety in Pediatrics (6-17) With Attention-Deficit/Hyperactivity Disorder (ADHD) Using CTx-1301 (Dexmethylphenidate)
This study has finished and is no longer accepting participants.
Multiple locations, including JacksonvilleA Phase 3, Dose-Optimized, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Parallel Efficacy and Safety Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Using CTx-1301 (Dexmethylphenidate)
This study has finished and is no longer accepting participants.
In Las Vegas
Pilot Explorations of Neurofeedback Issues in ADHD
This study has finished and is no longer accepting participants.
In ColumbusA Double-Blind Randomized Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including AabenraaPharmacokinetic Pharmacodynamic Studies of Methylphenidate Extended Release Products in Pediatric Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BostonWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.